October 14, 2026 / by Health Plan / Alerts, D-SNP Provider Alerts
Date: October 13, 2026 From: Health Plan of San Joaquin/Mountain Valley Health Plan (“Health Plan”) Therapeutics Committee To: Health Plan Facilities and Hospitals Type: Informational Subject: Medical Benefit Updates Business: Medicare Advantage D-SNP Effective December 21, 2026, the Pharmacy and Therapeutics Committee has approved the following changes to the medical benefit. CODE J2405 - INJECTION, [...]
Read more
Provider Training Due 12/31/26: Excellent Health Outcomes for All (EHOA)
October 22, 2026 / by Health Plan / Alerts, D-SNP Provider Alerts, Medi-Cal Provider Alerts
Date: October 21, 2026 From: Health Plan of San Joaquin/Mountain Valley Health Plan (“Health Plan”) To: Health Plan All Providers Type: Regulatory Subject: Provider Training Due 12/31/26: Excellent Health Outcomes for All (EHOA) Business: Medi-Cal Managed Care/Medicare Advantage D-SNP Providers and member-facing provider staff that have not yet completed Health Plan's Excellent Health Outcomes for [...]Read more
Medical Benefit Updates – Advantage D-SNP
October 14, 2026 / by Health Plan / Alerts, D-SNP Provider Alerts
Date: October 13, 2026 From: Health Plan of San Joaquin/Mountain Valley Health Plan (“Health Plan”) Therapeutics Committee To: Health Plan Facilities and Hospitals Type: Informational Subject: Medical Benefit Updates Business: Medicare Advantage D-SNP Effective December 21, 2026, the Pharmacy and Therapeutics Committee has approved the following changes to the medical benefit. CODE J2405 - INJECTION, [...]Read more
FDA Drug Recall Alert – 0.9% Sodium Chloride Injection, USP
October 1, 2026 / by Health Plan / Alerts, D-SNP Provider Alerts, Medi-Cal Provider Alerts
Date: October 01, 2026 From: Health Plan of San Joaquin/Mountain Valley Health Plan (“Health Plan”) To: Health Plan Practitioners, Facilities, and Hospitals Type: Informational/Educational Subject: FDA Drug Recall Alert – 0.9% Sodium Chloride Injection, USP Business: Medi-Cal Managed Care/Medicare Advantage D-SNP On September 21, 2026, the Food and Drug Administration (FDA) released a recall announcement [...]Read more
FDA Drug Recall Alert – Dexmedetomidine HCl in 0.9% Sodium Chloride Injection
October 1, 2026 / by Health Plan / Alerts, D-SNP Provider Alerts, Medi-Cal Provider Alerts
Date: September 30, 2026 From: Health Plan of San Joaquin/Mountain Valley Health Plan (“Health Plan”) To: Health Plan All Providers Type: Informational Subject: State of Emergency Declared Developing 2026–2027 El Niño Event Business: Medi-Cal Managed Care/Medicare Advantage D-SNP On September 21, 2026, the Food and Drug Administration (FDA) released a recall announcement on Dexmedetomidine HCl [...]Read more
State of Emergency Declared Developing 2026–2027 El Niño Event
October 1, 2026 / by Health Plan / Alerts, D-SNP Provider Alerts, Medi-Cal Provider Alerts
Date: September 30, 2026 From: Health Plan of San Joaquin/Mountain Valley Health Plan (“Health Plan”) To: Health Plan All Providers Type: Informational Subject: State of Emergency Declared Developing 2026–2027 El Niño Event Business: Medi-Cal Managed Care/Medicare Advantage D-SNP Governor Gavin Newsom has declared a State of Emergency for California in response to the developing 2026–2027 [...]Read more
FDA Drug Recall Alert – 3 Lots of Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) multi dose vial
September 14, 2026 / by Health Plan / Alerts, D-SNP Provider Alerts, Medi-Cal Provider Alerts
Date: September 11, 2026 From: Health Plan of San Joaquin/Mountain Valley Health Plan (“Health Plan”) To: Health Plan Practitioners, Facilities, and Hospitals Type: Informational/Educational Subject: FDA Drug Recall Alert – 3 Lots of Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) multi dose vial Business: Medi-Cal Managed Care/Medicare Advantage D-SNP On September 03, 2026, [...]Read more
Reminder: Self-Service Options Available on the Provider Portal
September 4, 2026 / by Health Plan / Alerts, D-SNP Provider Alerts, Medi-Cal Provider Alerts
Date: September 02, 2026 From: Health Plan of San Joaquin/Mountain Valley Health Plan (“Health Plan”) To: Health Plan All Network Providers Type: Informational/Educational Subject: Reminder: Self-Service Options Available on the Provider Portal Business: Medi-Cal Managed Care/Medicare Advantage D-SNP Health Plan would like to remind all network providers and facilities that the Provider Portal, Doctors Referral [...]Read more
FDA Drug Recall Alert – 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB®
September 4, 2026 / by Health Plan / Alerts, D-SNP Provider Alerts, Medi-Cal Provider Alerts
Date: September 02, 2026 From: Health Plan of San Joaquin/Mountain Valley Health Plan (“Health Plan”) To: Health Plan Practitioners, Facilities, and Hospitals Type: Informational/Educational Subject: FDA Drug Recall Alert – 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Business: Medi-Cal Managed Care/Medicare Advantage D-SNP On August 28, 2026, the Food and [...]Read more
FDA Drug Recall Alert – One Lot of Thyroid Tablets, USP 30 mg
August 31, 2026 / by Health Plan / Alerts, D-SNP Provider Alerts, Medi-Cal Provider Alerts
Date: August 31, 2026 From: Health Plan of San Joaquin/Mountain Valley Health Plan (“Health Plan”) To: Health Plan Practitioners, Facilities, and Hospitals Type: Informational/Educational Subject: FDA Drug Recall Alert – One Lot of Thyroid Tablets, USP 30 mg Business: Medi-Cal Managed Care/Medicare Advantage D-SNP On August 24, 2026, the Food and Drug Administration (FDA) released [...]Read more
FDA Drug Recall Alert – Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL Vials
August 21, 2026 / by Health Plan / Alerts, D-SNP Provider Alerts, Medi-Cal Provider Alerts
Date: August 20, 2026 From: Health Plan of San Joaquin/Mountain Valley Health Plan (“Health Plan”) To: Health Plan Practitioners, Facilities, and Hospitals Type: Informational/Educational Subject: FDA Drug Recall Alert – Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL Vials Business: Medi-Cal Managed Care/Medicare Advantage D-SNP On August 05, 2026, the Food and Drug Administration (FDA) released a [...]Read more